TrialThe New England journal of medicine2015
Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2,866 papers cite itlatest 60 shown
this paperpooled ittrialcites it